Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

• 收藏
• 分享

专利权人:

CYTLIMIC INC.

发明人:

Tomoya Miyakawa,Masaaki Oka,Shoichi Hazama,Koji Tamada,Keiko Udaka

申请号：

US16185734

公开号：

US10590179B2

申请日:

2018.11.09

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The present invention provides a peptide containing 8 or more consecutive amino acid residues in an amino acid sequence of any of SEQ ID NOS: 1 to 11 and consisting of 11 or less amino acid residues.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/